Paraneoplastic cerebellar degeneration with anti-Purkinje cell antibody associated with primary tubal cancer.
In patients with paraneoplastic cerebellar degeneration (PCD) due to gynecologic malignancies, a high titer of anti-Purkinje cell antibody (anti-Yo) has been found. Most patients, however, have limited oncologic disease at the time of onset of neurologic symptoms. We describe 2 cases of PCD due to tubal cancer with anti-Yo antibody. The onset of PCD occurred 4 and 14 months before the detection of cancer, respectively, and the presence of anti-Yo antibody facilitated early laparotomy in both cases. These patients, whose neurologic symptoms have not progressed, have survived without evidence of disease for 81 and 30 months since surgery, respectively. The presence of the anti-Yo antibody in patients with PCD warrants an aggressive approach to diagnosis and treatment of the underlying gynecologic cancer.
Matsushita
H
H
Department of Obstetrics and Gynecology, Niigata University School of Medicine, Japan.
Kodama
S
S
Aoki
Y
Y
Tanaka
K
K
Tanaka
K
K
Saito
N
N
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy; D000368:Aged; D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000276:immunology; D002524:Cerebellar Ataxia / Q000175:diagnosis / Q000276:immunology; D002526:Cerebellar Diseases / Q000175:diagnosis*; D004268:DNA-Binding Proteins / Q000276:immunology*; D005185:Fallopian Tube Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000276:immunology*; D009419:Nerve Tissue Proteins; D010257:Paraneoplastic Syndromes / Q000175:diagnosis*
D001323:Autoantibodies; D001324:Autoantigens; C063762:CDR1 protein, human; C095184:CDR2 protein, human; D004268:DNA-Binding Proteins; D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins